Sofosbuvir-Velpatasvir Successful in Hep C Regardless of Genotype

Hepatitis C Therapy: Remaining Challenges and Solutions

Computer simulation of enzyme improves understanding of hepatitis C

Fas Ligand Based Immunotherapy: A Potent and Effective Neoadjuvant with Checkpoint Inhibitor Properties, or a Systemically Toxic Promoter of Tumor Growth?

CDC: Guidelines For Viral Hepatitis Surveillance And Case Management

Expensive Hep C Drugs Denied to Almost Half of Medicaid Patients

Hepatitis C linked to increased risk of liver cancer, other cancers

Burden of Hep C Virus Substantial Despite Oral Antiviral Therapy

May 19 is Hepatitis Testing Day!

Hepatitis C: elbasvir/grazoprevir combo tops popular treatment